Use of antihypertensives — medications used to treat high blood pressure — is associated with milder disease, slower progression,…
Ana Pena, PhD
Ana is a molecular biologist with a passion for discovery and communication. As a science writer, she looks for connecting the public, in particular patients and healthcare providers, with clear and quality information about the latest medical advances. Ana holds a Ph.D. in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in infectious diseases, epigenetics, and gene expression.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ana Pena, PhD
Researchers have developed a new class of compounds that tackles the root cause of Huntington’s disease, opening up new…
Massive inflammation and other changes in the striatum, an area of the brain selectively destroyed in…
People at a pre-symptomatic, or premanifest, stage of Huntington’s disease (HD) have subtle speech alterations that may be used…
Measuring the seeding activity of mutant huntingtin (mHTT) protein — its ability to trigger protein aggregation — could be…
Genetic Testing for Huntington’s Declined Due to Lack of Effective Treatments, U.S. Study Shows
Most people at risk for Huntington’s decide not to undergo genetic testing for the disease due to the lack…
Pain Prevalent in Huntington’s Patients but Burden Lower Than in General Population, Study Finds
Although many patients with Huntington’s disease (HD) experience pain, they report this problem has less of an…
Defects in cells’ “cleaning system,” known as autophagy, may underlie nerve cell degeneration in early stages of Huntington’s disease, according…